|
"Some researchers (see slide link, below) have found Topo IIa overexpression or amplification in the absence of HER2+ but Slamon says it only happens when HER2 is positive."
Sounds like some fundamental areas of this research might be unsettled.
I'd like to see how this matches up with the Doxo, Zoledronic acid combo trial as the results come in later this year.
I wish there was a similar trial using taxanes instead.
|